Crafton partners with biotechnology companies, pharmaceutical companies, academic institutions, and public-sector organizations to advance next-generation mRNA medicines.

Collaboration type	What Crafton Provides	Partner Benefit
Co-development	Platform technology, mRNA know-how, preclinical development	Shared advancement of therapeutic candidates
Platform collaboration	PureCap®, delivery evaluation, CRAFT capabilities	Access to differentiated mRNA technologies
Public-health partnership	Vaccine development and preparedness capability	Regional mRNA readiness and rapid response